Lead faculty, cancer immunotherapy & adoptive cell therapy (Division of Hematology/Oncology, Department of Medicine, School of Medicine)

The Hematology/Oncology Division of the Department of Medicine at the University of California, Irvine (UCI) is seeking candidates for a senior physician/scientist tenure-track faculty member position with experience and expertise in the development of immunotherapy of cancer within the broad topic of adoptive cellular therapy (e.g., antigen discovery, CARs, resistance mechanisms, tumor microenvironment as it impacts immunotherapy). This position is at the level of Associate or full Professor, depending upon the candidate's qualifications, experience, and achievements. The successful candidate will be charged with the development, growth, and leadership of a research program in the broad area of adoptive cellular immunotherapy that can be integrated with our expanding, FACT-accredited hematopoietic stem cell transplant (HSCT) program and will be expected to engage in translational and clinical research, clinical education, and potentially limited patient care.

The environment and infrastructure at UCI and UCI Health are ideal for fostering the growth of a cancer adoptive cell therapy (ACT) program. UCI is home to the Chao Family Comprehensive Cancer Center (CFCCC), one of 55 NCI-designated comprehensive cancer centers, and is one of only 23 institutions also holding an NCATS-funded Clinical Translational Science Award. In addition to the UCI Medical Center located in Orange, a new $1.3 billion medical center is under construction on the UCI Irvine campus that will include a new 220,000 sq. ft. outpatient cancer center and a 144 bed specialty hospital that will be the new home of the HSCT and ACT programs. Additional facilities include a newly opened seven room cGMP cellular production facility. It is anticipated that the ACT program will engage with investigators in the CIRM-funded Sue & Bill Gross Stem Cell Institute, the UCI Institute for Immunology, the CFCCC, and the clinical investigators of UCI Health.

To Apply: https://recruit.ap.uci.edu/analyst/recruitments/JPF08304)

Competitive candidates are expected to have a defined research focus, a strong record of extramural research funding, strong scholarly track record, and other accomplishments. Applicants must hold an M.D., PhD, or equivalent degree. Holding a PhD or equivalent in addition to the MD or equivalent is preferred but not essential. A successful physician scientist candidate should hold subspecialty certification in an oncologic subspecialty including but not limited to; gynecologic oncology, hematology, medical oncology, or surgical oncology and must possess or be eligible to obtain an active medical practice license in the State of California. Candidates are expected to lead and conduct research within their specific area of focus, with some clinical/translational component.

• 5-7 required (contact information only)

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC anti-discrimination policy.

As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.